Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
(Q36615874)
scientific article published on May 2005
scientific article published on May 2005
Language:
Current Data About
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
other details
description | scientific article published on May 2005 |
External Links
(P356) |
10.1038/SJ.BJC.6602584
|
(P698) |
15870716
|
(P932) |
2361774
|
(P5875) |
7867195
|
(P6179) |
1028625172
|